Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 53 | 2018 | 1390 | 6.080 |
Why?
|
Polymorphism, Single Nucleotide | 65 | 2019 | 1080 | 5.740 |
Why?
|
African Americans | 62 | 2018 | 1375 | 5.590 |
Why?
|
Genome-Wide Association Study | 51 | 2019 | 546 | 3.860 |
Why?
|
Genetic Predisposition to Disease | 39 | 2019 | 840 | 3.760 |
Why?
|
Lipoproteins, HDL | 18 | 2018 | 247 | 2.690 |
Why?
|
Apolipoproteins | 16 | 2016 | 197 | 2.620 |
Why?
|
Diabetic Nephropathies | 13 | 2016 | 195 | 2.580 |
Why?
|
Genetic Variation | 15 | 2018 | 251 | 2.500 |
Why?
|
Kidney Failure, Chronic | 16 | 2018 | 522 | 2.450 |
Why?
|
Insulin Resistance | 20 | 2018 | 451 | 2.320 |
Why?
|
Adiponectin | 8 | 2017 | 103 | 1.780 |
Why?
|
Atherosclerosis | 15 | 2018 | 730 | 1.740 |
Why?
|
Genotype | 32 | 2019 | 735 | 1.620 |
Why?
|
European Continental Ancestry Group | 27 | 2019 | 1132 | 1.620 |
Why?
|
Middle Aged | 72 | 2019 | 10954 | 1.580 |
Why?
|
Genetic Loci | 15 | 2019 | 147 | 1.470 |
Why?
|
Hispanic Americans | 18 | 2019 | 903 | 1.440 |
Why?
|
Male | 81 | 2019 | 18037 | 1.410 |
Why?
|
Female | 80 | 2019 | 18414 | 1.380 |
Why?
|
Humans | 107 | 2019 | 29614 | 1.370 |
Why?
|
Insulin | 8 | 2018 | 347 | 1.350 |
Why?
|
Membrane Proteins | 10 | 2019 | 257 | 1.340 |
Why?
|
Blood Glucose | 12 | 2018 | 469 | 1.220 |
Why?
|
Adult | 50 | 2019 | 8535 | 1.180 |
Why?
|
Gene Frequency | 16 | 2018 | 225 | 1.130 |
Why?
|
Aged | 51 | 2019 | 9617 | 1.120 |
Why?
|
Mexican Americans | 5 | 2019 | 59 | 1.030 |
Why?
|
Adiposity | 7 | 2017 | 192 | 1.030 |
Why?
|
Obesity | 9 | 2017 | 1082 | 1.000 |
Why?
|
Brain | 7 | 2018 | 944 | 0.980 |
Why?
|
Case-Control Studies | 19 | 2018 | 861 | 0.960 |
Why?
|
Kidney Diseases | 6 | 2016 | 239 | 0.950 |
Why?
|
Cognition Disorders | 5 | 2018 | 391 | 0.910 |
Why?
|
Genetic Association Studies | 12 | 2019 | 148 | 0.910 |
Why?
|
Phenotype | 12 | 2019 | 634 | 0.870 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2019 | 273 | 0.840 |
Why?
|
Lipids | 5 | 2019 | 215 | 0.810 |
Why?
|
Alleles | 10 | 2017 | 252 | 0.800 |
Why?
|
Quantitative Trait Loci | 5 | 2019 | 141 | 0.760 |
Why?
|
Albuminuria | 7 | 2017 | 178 | 0.750 |
Why?
|
Glucose | 3 | 2018 | 165 | 0.710 |
Why?
|
Mutation, Missense | 2 | 2014 | 48 | 0.710 |
Why?
|
Cohort Studies | 18 | 2018 | 1708 | 0.710 |
Why?
|
Vitamin D | 4 | 2018 | 175 | 0.680 |
Why?
|
Body Mass Index | 8 | 2018 | 876 | 0.630 |
Why?
|
Cognition | 6 | 2017 | 535 | 0.630 |
Why?
|
Tissue Donors | 3 | 2016 | 167 | 0.590 |
Why?
|
Lipase | 3 | 2019 | 28 | 0.590 |
Why?
|
Risk Factors | 15 | 2018 | 3612 | 0.580 |
Why?
|
Fibroblast Growth Factors | 2 | 2017 | 34 | 0.560 |
Why?
|
Adipose Tissue | 3 | 2017 | 332 | 0.560 |
Why?
|
Glomerulonephritis | 2 | 2018 | 21 | 0.550 |
Why?
|
Young Adult | 16 | 2019 | 2432 | 0.540 |
Why?
|
Kidney Transplantation | 4 | 2016 | 353 | 0.530 |
Why?
|
Cross-Sectional Studies | 11 | 2018 | 1398 | 0.490 |
Why?
|
PPAR gamma | 1 | 2014 | 45 | 0.490 |
Why?
|
Epistasis, Genetic | 4 | 2018 | 44 | 0.480 |
Why?
|
Haplotypes | 8 | 2015 | 221 | 0.480 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2013 | 2 | 0.470 |
Why?
|
Cation Transport Proteins | 1 | 2014 | 24 | 0.470 |
Why?
|
Graft Survival | 2 | 2016 | 228 | 0.470 |
Why?
|
Glomerular Filtration Rate | 8 | 2019 | 289 | 0.470 |
Why?
|
Quantitative Trait, Heritable | 2 | 2019 | 47 | 0.470 |
Why?
|
Blood Pressure | 7 | 2018 | 813 | 0.470 |
Why?
|
Hypertension | 7 | 2018 | 918 | 0.470 |
Why?
|
Molecular Motor Proteins | 3 | 2014 | 58 | 0.470 |
Why?
|
Adipocytes | 1 | 2014 | 79 | 0.470 |
Why?
|
Myosin Heavy Chains | 3 | 2014 | 86 | 0.470 |
Why?
|
Fasting | 4 | 2017 | 93 | 0.450 |
Why?
|
Continental Population Groups | 4 | 2019 | 221 | 0.450 |
Why?
|
Lipid Metabolism | 3 | 2019 | 101 | 0.440 |
Why?
|
Adolescent | 14 | 2019 | 3284 | 0.440 |
Why?
|
Metabolome | 2 | 2018 | 31 | 0.440 |
Why?
|
African Continental Ancestry Group | 6 | 2019 | 350 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 8 | 2018 | 1229 | 0.430 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 68 | 0.420 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 155 | 0.410 |
Why?
|
Cell Differentiation | 1 | 2014 | 438 | 0.410 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 72 | 0.400 |
Why?
|
Family | 4 | 2018 | 105 | 0.400 |
Why?
|
Linkage Disequilibrium | 5 | 2019 | 192 | 0.380 |
Why?
|
Bone Density | 4 | 2015 | 183 | 0.380 |
Why?
|
Homeostasis | 5 | 2018 | 127 | 0.380 |
Why?
|
Gene Expression Regulation | 5 | 2016 | 484 | 0.370 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 139 | 0.360 |
Why?
|
Aged, 80 and over | 10 | 2019 | 3771 | 0.360 |
Why?
|
Nerve Tissue Proteins | 3 | 2019 | 118 | 0.340 |
Why?
|
Aspartate Aminotransferases | 1 | 2019 | 28 | 0.340 |
Why?
|
Alanine Transaminase | 1 | 2019 | 45 | 0.340 |
Why?
|
Transcription Factors | 4 | 2019 | 174 | 0.340 |
Why?
|
Lod Score | 5 | 2017 | 71 | 0.330 |
Why?
|
Triglycerides | 5 | 2019 | 219 | 0.330 |
Why?
|
United States | 9 | 2018 | 3695 | 0.320 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2018 | 4 | 0.320 |
Why?
|
Glaucoma, Open-Angle | 2 | 2018 | 17 | 0.320 |
Why?
|
Lupus Nephritis | 1 | 2018 | 30 | 0.310 |
Why?
|
Smoking | 3 | 2019 | 441 | 0.310 |
Why?
|
Kidney Function Tests | 5 | 2019 | 102 | 0.310 |
Why?
|
Fibrinolysis | 1 | 2017 | 7 | 0.300 |
Why?
|
Liver | 4 | 2019 | 465 | 0.300 |
Why?
|
Models, Genetic | 2 | 2018 | 95 | 0.300 |
Why?
|
INDEL Mutation | 1 | 2017 | 10 | 0.300 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2017 | 46 | 0.300 |
Why?
|
Signal Transduction | 2 | 2016 | 674 | 0.290 |
Why?
|
NFI Transcription Factors | 1 | 2016 | 12 | 0.280 |
Why?
|
Laminin | 1 | 2016 | 13 | 0.280 |
Why?
|
Islets of Langerhans | 2 | 2016 | 75 | 0.280 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.280 |
Why?
|
Apolipoproteins E | 1 | 2016 | 98 | 0.280 |
Why?
|
Odds Ratio | 5 | 2017 | 448 | 0.270 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 95 | 0.270 |
Why?
|
Parathyroid Hormone | 1 | 2016 | 40 | 0.270 |
Why?
|
Linear Models | 4 | 2019 | 427 | 0.270 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 6 | 0.270 |
Why?
|
Creatinine | 4 | 2017 | 175 | 0.270 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 72 | 0.270 |
Why?
|
Alcohol Drinking | 2 | 2019 | 249 | 0.270 |
Why?
|
Muscles | 1 | 2016 | 56 | 0.270 |
Why?
|
Cardiovascular Diseases | 4 | 2017 | 1058 | 0.270 |
Why?
|
Coronary Disease | 1 | 2017 | 202 | 0.270 |
Why?
|
Fatty Liver | 2 | 2013 | 66 | 0.260 |
Why?
|
Vitamin D-Binding Protein | 1 | 2015 | 10 | 0.260 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 211 | 0.260 |
Why?
|
Caveolin 1 | 1 | 2015 | 13 | 0.260 |
Why?
|
Stress, Physiological | 1 | 2015 | 44 | 0.260 |
Why?
|
Microsatellite Repeats | 1 | 2014 | 25 | 0.250 |
Why?
|
Mutation | 1 | 2017 | 475 | 0.250 |
Why?
|
Brain Diseases | 1 | 2014 | 40 | 0.240 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 141 | 0.240 |
Why?
|
Open Reading Frames | 1 | 2014 | 19 | 0.240 |
Why?
|
Selenoprotein P | 1 | 2013 | 2 | 0.230 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 24 | 0.230 |
Why?
|
Autoantigens | 1 | 2013 | 16 | 0.230 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 143 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2013 | 72 | 0.230 |
Why?
|
Genetics, Population | 1 | 2013 | 32 | 0.230 |
Why?
|
Asian Continental Ancestry Group | 4 | 2019 | 110 | 0.230 |
Why?
|
Renal Dialysis | 1 | 2016 | 265 | 0.220 |
Why?
|
Dopamine | 1 | 2016 | 227 | 0.220 |
Why?
|
Cholesterol, LDL | 4 | 2019 | 165 | 0.220 |
Why?
|
Osteoporosis | 1 | 2013 | 52 | 0.220 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 110 | 0.220 |
Why?
|
Ethnic Groups | 2 | 2016 | 440 | 0.220 |
Why?
|
Energy Metabolism | 2 | 2018 | 139 | 0.210 |
Why?
|
Organ Size | 3 | 2018 | 196 | 0.210 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 100 | 0.200 |
Why?
|
Vitamin D Deficiency | 2 | 2018 | 91 | 0.200 |
Why?
|
Calcinosis | 1 | 2012 | 143 | 0.200 |
Why?
|
Inflammation | 1 | 2015 | 511 | 0.200 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 496 | 0.200 |
Why?
|
Coronary Artery Disease | 2 | 2013 | 377 | 0.190 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 180 | 0.190 |
Why?
|
Multivariate Analysis | 3 | 2017 | 638 | 0.190 |
Why?
|
Neuropsychological Tests | 3 | 2017 | 383 | 0.190 |
Why?
|
Animals | 5 | 2017 | 7341 | 0.180 |
Why?
|
Life Style | 3 | 2019 | 372 | 0.180 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 711 | 0.180 |
Why?
|
Risk | 3 | 2016 | 293 | 0.180 |
Why?
|
Glucose Tolerance Test | 3 | 2017 | 126 | 0.170 |
Why?
|
Body Weight | 1 | 2011 | 290 | 0.170 |
Why?
|
Mice | 3 | 2017 | 2388 | 0.170 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2018 | 11 | 0.160 |
Why?
|
Cholesterol, HDL | 3 | 2019 | 168 | 0.150 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 67 | 0.150 |
Why?
|
Energy Intake | 1 | 2017 | 120 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 73 | 0.140 |
Why?
|
Genome, Human | 2 | 2017 | 129 | 0.140 |
Why?
|
Insulin-Secreting Cells | 2 | 2017 | 53 | 0.140 |
Why?
|
Demography | 2 | 2017 | 105 | 0.140 |
Why?
|
Chromosome Mapping | 3 | 2019 | 192 | 0.140 |
Why?
|
Risk Assessment | 3 | 2017 | 1329 | 0.140 |
Why?
|
Base Sequence | 2 | 2014 | 255 | 0.140 |
Why?
|
Reproducibility of Results | 3 | 2018 | 727 | 0.130 |
Why?
|
Carrier Proteins | 2 | 2018 | 136 | 0.130 |
Why?
|
Body Size | 1 | 2015 | 31 | 0.130 |
Why?
|
Coronary Vessels | 2 | 2017 | 151 | 0.130 |
Why?
|
Claudins | 1 | 2015 | 8 | 0.130 |
Why?
|
Atrophy | 2 | 2015 | 52 | 0.130 |
Why?
|
Mutant Chimeric Proteins | 1 | 2014 | 5 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 7 | 0.120 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2014 | 9 | 0.120 |
Why?
|
HMGA2 Protein | 1 | 2014 | 13 | 0.120 |
Why?
|
Ion Transport | 1 | 2014 | 5 | 0.120 |
Why?
|
Proinsulin | 1 | 2014 | 8 | 0.120 |
Why?
|
Physical Fitness | 1 | 2015 | 120 | 0.120 |
Why?
|
Prediabetic State | 1 | 2014 | 58 | 0.120 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 24 | 0.120 |
Why?
|
Graft Rejection | 1 | 2015 | 149 | 0.120 |
Why?
|
Mexico | 1 | 2013 | 64 | 0.120 |
Why?
|
Hela Cells | 1 | 2013 | 88 | 0.120 |
Why?
|
Exercise | 1 | 2019 | 610 | 0.120 |
Why?
|
Indians, North American | 1 | 2013 | 108 | 0.110 |
Why?
|
Genetic Markers | 2 | 2013 | 124 | 0.110 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 366 | 0.110 |
Why?
|
Diabetes Complications | 2 | 2014 | 171 | 0.110 |
Why?
|
Gout | 1 | 2012 | 14 | 0.110 |
Why?
|
Uric Acid | 1 | 2012 | 24 | 0.110 |
Why?
|
Metabolomics | 2 | 2018 | 46 | 0.110 |
Why?
|
Mice, Knockout | 1 | 2014 | 425 | 0.110 |
Why?
|
Pedigree | 2 | 2018 | 135 | 0.110 |
Why?
|
RNA, Messenger | 1 | 2013 | 523 | 0.100 |
Why?
|
Enzymes | 1 | 2011 | 5 | 0.100 |
Why?
|
Follow-Up Studies | 2 | 2017 | 2124 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2016 | 3128 | 0.090 |
Why?
|
Introns | 2 | 2016 | 40 | 0.090 |
Why?
|
Time Factors | 2 | 2016 | 2014 | 0.090 |
Why?
|
gamma-Glutamyltransferase | 1 | 2019 | 9 | 0.090 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2018 | 4 | 0.080 |
Why?
|
Proteins | 2 | 2017 | 141 | 0.080 |
Why?
|
Intraocular Pressure | 2 | 2018 | 25 | 0.080 |
Why?
|
Age Factors | 2 | 2016 | 1122 | 0.080 |
Why?
|
Molecular Weight | 1 | 2017 | 42 | 0.080 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 14 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2017 | 56 | 0.070 |
Why?
|
C-Peptide | 1 | 2017 | 25 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2017 | 60 | 0.070 |
Why?
|
Public Health | 1 | 2017 | 76 | 0.070 |
Why?
|
Heterozygote | 1 | 2016 | 53 | 0.070 |
Why?
|
Computational Biology | 1 | 2017 | 86 | 0.070 |
Why?
|
Minisatellite Repeats | 1 | 2016 | 8 | 0.070 |
Why?
|
Disease Progression | 1 | 2018 | 576 | 0.070 |
Why?
|
Phosphates | 1 | 2015 | 25 | 0.070 |
Why?
|
Iliac Artery | 1 | 2015 | 46 | 0.070 |
Why?
|
Factor XIII | 1 | 2015 | 3 | 0.070 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 5 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2015 | 19 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2015 | 97 | 0.060 |
Why?
|
Tissue and Organ Procurement | 1 | 2016 | 69 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2015 | 41 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 294 | 0.060 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 97 | 0.060 |
Why?
|
Lipoproteins, LDL | 1 | 2015 | 77 | 0.060 |
Why?
|
Databases, Nucleic Acid | 1 | 2014 | 6 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 440 | 0.060 |
Why?
|
Prevalence | 1 | 2017 | 912 | 0.060 |
Why?
|
Donor Selection | 1 | 2015 | 31 | 0.060 |
Why?
|
Stroop Test | 1 | 2014 | 5 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 713 | 0.060 |
Why?
|
Memory | 1 | 2016 | 188 | 0.060 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 52 | 0.060 |
Why?
|
Systole | 2 | 2018 | 88 | 0.060 |
Why?
|
Diastole | 2 | 2018 | 91 | 0.060 |
Why?
|
Albumins | 1 | 2014 | 39 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2014 | 28 | 0.060 |
Why?
|
Radiography | 1 | 2015 | 355 | 0.060 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2014 | 11 | 0.060 |
Why?
|
Registries | 1 | 2016 | 280 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 226 | 0.060 |
Why?
|
Complement Factor H | 1 | 2014 | 5 | 0.060 |
Why?
|
Europe | 2 | 2016 | 78 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2015 | 182 | 0.060 |
Why?
|
Exons | 1 | 2014 | 49 | 0.060 |
Why?
|
Angiotensinogen | 1 | 2014 | 73 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2014 | 35 | 0.060 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2013 | 13 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 471 | 0.060 |
Why?
|
Incidence | 1 | 2017 | 1128 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 321 | 0.060 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 68 | 0.060 |
Why?
|
Founder Effect | 1 | 2013 | 5 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 185 | 0.060 |
Why?
|
Heart Diseases | 1 | 2014 | 99 | 0.060 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2013 | 8 | 0.060 |
Why?
|
Lysophospholipase | 1 | 2013 | 5 | 0.060 |
Why?
|
Lectins, C-Type | 1 | 2013 | 10 | 0.060 |
Why?
|
Cause of Death | 1 | 2014 | 222 | 0.060 |
Why?
|
Osmolar Concentration | 1 | 2012 | 19 | 0.050 |
Why?
|
DNA | 1 | 2014 | 209 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2012 | 62 | 0.050 |
Why?
|
Sex Factors | 1 | 2013 | 636 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2011 | 3 | 0.050 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2011 | 4 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2011 | 20 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2013 | 233 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 875 | 0.050 |
Why?
|
Prognosis | 1 | 2014 | 1373 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor B | 1 | 2019 | 5 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2019 | 10 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2013 | 424 | 0.040 |
Why?
|
Brazil | 1 | 2019 | 13 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2019 | 33 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 45 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2019 | 57 | 0.040 |
Why?
|
ROC Curve | 1 | 2018 | 149 | 0.040 |
Why?
|
Body Constitution | 1 | 2018 | 26 | 0.040 |
Why?
|
Visual Fields | 1 | 2018 | 25 | 0.040 |
Why?
|
Syndrome | 1 | 2017 | 66 | 0.040 |
Why?
|
Drosophila | 1 | 2017 | 34 | 0.040 |
Why?
|
Prospective Studies | 1 | 2012 | 2050 | 0.040 |
Why?
|
Visual Acuity | 1 | 2018 | 69 | 0.040 |
Why?
|
Finland | 1 | 2017 | 2 | 0.040 |
Why?
|
Cholesterol | 1 | 2019 | 239 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 16 | 0.040 |
Why?
|
Sample Size | 1 | 2016 | 37 | 0.030 |
Why?
|
Research Design | 1 | 2018 | 290 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2015 | 33 | 0.030 |
Why?
|
Alabama | 1 | 2015 | 34 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2015 | 5 | 0.030 |
Why?
|
Genome | 1 | 2014 | 40 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2015 | 171 | 0.030 |
Why?
|
Databases, Factual | 1 | 2014 | 333 | 0.030 |
Why?
|
Inhibins | 1 | 2012 | 3 | 0.030 |
Why?
|
Survival Rate | 1 | 2015 | 797 | 0.030 |
Why?
|
tRNA Methyltransferases | 1 | 2012 | 5 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2012 | 6 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2012 | 13 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 8 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 39 | 0.030 |
Why?
|
Asia | 1 | 2011 | 18 | 0.030 |
Why?
|
Africa | 1 | 2011 | 23 | 0.030 |
Why?
|
Child | 1 | 2018 | 2234 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2012 | 455 | 0.030 |
Why?
|
North Carolina | 1 | 2015 | 1430 | 0.020 |
Why?
|
Texas | 1 | 2010 | 36 | 0.020 |
Why?
|
Colorado | 1 | 2010 | 40 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2010 | 28 | 0.020 |
Why?
|
Family Health | 1 | 2010 | 78 | 0.020 |
Why?
|
Gene Expression | 1 | 2010 | 334 | 0.020 |
Why?
|
Stroke | 1 | 2011 | 552 | 0.020 |
Why?
|